Crossmark

Outcomes following calcium channel blocker exposures reported to a poison information center

Crossref DOI link: https://doi.org/10.1186/s40360-018-0271-9

Published Online: 2018-11-27

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Christensen, Mikkel B. https://orcid.org/0000-0002-8774-1797
Petersen, Kasper M.

Bøgevig, Søren

Al-Gibouri, Salam

Jimenez-Solem, Espen

Dalhoff, Kim P.

Petersen, Tonny S.

Andersen, Jon T.
License Information

Text and Data Mining valid from 2018-11-27
More Information

Article History

Received: 14 September 2018

Accepted: 13 November 2018

First Online: 27 November 2018

Ethics approval and consent to participate

: The study was approved by the Danish Data Protection Agency (2012-58-0004). In Denmark, the Act on Processing of Personal Data does not require obtained consent or ethical approval for anonymized retrospective registry studies. The Danish Patient Safety Authority approved (journal number 3–3013-1382/1) the retrieval of data from the DPIC database and from the local clinical departments, who forwarded then forwarded the clinical data from medical charts on non-anonymous poisoned patients.

: Not applicable. In Denmark, the Act on Processing of Personal Data does not require obtained consent or ethical approval for anonymized retrospective registry studies.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.